ONCOSEC MEDICAL INCORPORATED: 10-Q filed 2018-03-09
What ONCOSEC MEDICAL INCORPORATED reported in its quarterly report filed 2018-03-09 (fiscal Q2 2018): 27 published measures, 70 facts as tagged in accession 0001493152-18-003167.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2018-03-09
- Fiscal period
- fiscal Q2 2018
- Accession
- 0001493152-18-003167 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ONCOSEC MEDICAL INCORPORATED filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | 22,122,205 | USD | |
| At 2017-07-31 | 15,232,909 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | 4,091,134 | USD | |
| At 2017-07-31 | 4,536,927 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | 18,031,071 | USD | |
| At 2017-07-31 | 10,695,982 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | 17,903,581 | USD | |
| At 2017-07-31 | 11,444,676 | USD | |
| At 2017-01-31 | 20,541,455 | USD | |
| At 2016-07-31 | 28,746,224 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-11-01 to 2018-01-31 | -10,736,101 | USD | 92 |
| 2017-08-01 to 2018-01-31 | -16,636,553 | USD | 184 |
| 2016-11-01 to 2017-01-31 | -5,387,311 | USD | 92 |
| 2016-08-01 to 2017-01-31 | -10,990,894 | USD | 184 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-08-01 to 2018-01-31 | 8,213 | USD | 184 |
| 2016-08-01 to 2017-01-31 | 9,578 | USD | 184 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | -111,581,008 | USD | |
| At 2017-07-31 | -94,944,455 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-11-01 to 2018-01-31 | 951 | USD | 92 |
| 2017-08-01 to 2018-01-31 | 951 | USD | 184 |
| 2016-08-01 to 2017-01-31 | 1,391 | USD | 184 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | 2,224,934 | USD | |
| At 2017-07-31 | 2,410,099 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-08-01 to 2018-01-31 | 2,981,509 | USD | 184 |
| 2016-08-01 to 2017-01-31 | 2,596,280 | USD | 184 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-11-01 to 2018-01-31 | -8,285,033 | USD | 92 |
| 2017-08-01 to 2018-01-31 | -14,212,221 | USD | 184 |
| 2016-11-01 to 2017-01-31 | -5,429,965 | USD | 92 |
| 2016-08-01 to 2017-01-31 | -11,078,275 | USD | 184 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | 19,584,042 | USD | |
| At 2017-07-31 | 12,513,623 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | 2,912,426 | USD | |
| At 2017-07-31 | 3,395,974 | USD |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | 35,827,912 | shares | |
| At 2017-07-31 | 21,618,194 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | 20,245 | USD | |
| At 2017-07-31 | -3,620 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | 18,031,071 | USD | |
| At 2017-07-31 | 10,695,982 | USD | |
| At 2017-01-31 | 19,700,926 | USD | |
| At 2016-07-31 | 28,053,104 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | 3,209,013 | USD | |
| At 2017-07-31 | 3,233,768 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | 984,079 | USD | |
| At 2017-07-31 | 823,669 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | 313,229 | USD | |
| At 2017-07-31 | 309,187 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | 1,178,708 | USD | |
| At 2017-07-31 | 1,140,953 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-01-31 | 161,127 | USD | |
| At 2017-07-31 | 114,841 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-11-01 to 2018-01-31 | -10,735,150 | USD | 92 |
| 2017-08-01 to 2018-01-31 | -16,635,602 | USD | 184 |
| 2016-11-01 to 2017-01-31 | -5,387,311 | USD | 92 |
| 2016-08-01 to 2017-01-31 | -10,989,503 | USD | 184 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-08-01 to 2018-01-31 | -111,600,000 | USD | 184 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-11-01 to 2018-01-31 | 5,290,096 | USD | 92 |
| 2017-08-01 to 2018-01-31 | 7,804,135 | USD | 184 |
| 2016-11-01 to 2017-01-31 | 2,547,354 | USD | 92 |
| 2016-08-01 to 2017-01-31 | 5,095,924 | USD | 184 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-11-01 to 2018-01-31 | 95,000 | USD | 92 |
| 2017-08-01 to 2018-01-31 | 190,973 | USD | 184 |
| 2016-11-01 to 2017-01-31 | 94,000 | USD | 92 |
| 2016-08-01 to 2017-01-31 | 189,039 | USD | 184 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-11-01 to 2018-01-31 | 15,279 | USD | 92 |
| 2017-08-01 to 2018-01-31 | 42,015 | USD | 184 |
| 2016-11-01 to 2017-01-31 | 42,654 | USD | 92 |
| 2016-08-01 to 2017-01-31 | 88,772 | USD | 184 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-08-01 to 2018-01-31 | 951 | USD | 184 |
| 2016-08-01 to 2017-01-31 | 1,391 | USD | 184 |
Inspect the source
- Entity
- ONCOSEC MEDICAL INCORPORATED / CIK 0001444307
- Captured
- SEC response SHA-256
326bcab6a98b5e6098a865fe967c999ac8b3247d9466d112c5306da6df2f5607
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001444307.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))